NIH Requires New Biosketch Format for Due Dates on or After January 25, 2015
The National Institutes of Health (NIH) recently announced that a new biosketch format will be required for all applications submitted for FY2016 funding, which begins with due dates of January 25, 2015.
The NIH has been piloting a planned modification of the biosketch since June 2012. The new format increases the page limit from 4 to 5 pages and increases the number of peer-reviewed publications from 15 to 20.
The new format allows investigators to include a link to a complete listing of their publications in SciENcv or My Bibliography. Within the next few weeks, the NIH will update SciENcv to accommodate the new biosketch format.
Visit the NIH website under the heading “Additional Format Pages” to obtain templates for the new biosketch format: http://grants.nih.gov/grants/funding/424/index.htm.
Local Assistance Available with New Biosketch Formatting
Contact Kathy Blazer, Interim Director, Cleveland Health Sciences Library, (216-368-1361 or email@example.com) if interested in having Kathy conduct a departmental information session, or to answer individual questions.
Review the Health Sciences Library's slide presentation at: http://www.case.edu/chsl/library/NIHBiosketch.pptx.
Patient-Centered Outcomes Research Institute (PCORI)
Pipeline to Proposal Awards Tier I - Pre-Engagement/Community Projects fund the building of the community and capacity necessary to later develop a patient-centered comparative effectiveness research (CER) project addressing the issue of interest to the awardee
The Tier I awards are for individuals or groups who are not usual candidates for research funding. This program is intended to support those individuals and groups with critically important ideas who may not have other opportunities for research funding. In order to qualify for Tier I funding, you must demonstrate success in a past community-building project. The project doesn’t have to have been health-related. You need to explain how you engaged the community and formed partnerships to achieve your goal and how, by building relationships and forming partnerships, you were able to overcome any obstacles.
Letter of Intent (LOI) deadline: December 23, 2014
Application Deadline: February 16, 2015
Funds available up to: $15,000
For more information, visit the PCORI website.
Division of Infectious Diseases & HIV Medicine, CWRU and UH Case Medical Center
Announcement of Infectious Diseases Research Support from STERIS Corporation
The Division of Infectious Diseases & HIV Medicine at Case Western Reserve University and University Hospitals Case Medical Center, with funds from STERIS Corporation, will provide seed money to faculty to foster research in emerging and healthcare-associated infections.
Announcement of Infectious Diseases Research Support from the Infectious Diseases & Immunology Institute (IDII)
The Infectious Diseases & Immunology Institute (IDII) at Case Western Reserve University will provide seed money to young investigators (within 5 years of appointment) to foster interdisciplinary research in infectious diseases and immunology.
For more information on these opportunities, please contact Martha Salata at 844-1988 or firstname.lastname@example.org or visit the Center’s website.
Department of Defense
OFFICE OF STRATEGIC INITIATIVES - CALL FOR SUBMISSIONS
U.S. Army Medical Research and Materiel Command (USAMRMC) Broad Agency Announcement - BAA -15-1
Apply early. Funding is limited and subject to availability.
The BAA is continuously open, and accepts proposals on a rolling basis. Pre-proposals may be submitted and will be evaluated at any time throughout the year.
Scope: The USAMRMC's mission is to provide solutions to medical problems of importance to the American warfighter. Projects must pertain to at least one of the research areas of interest outlined in the BAA.
Funding: Budgets are not capped and must reflect the scope of the work. Funding can be requested for up to 5 years.
Areas of interest:
1. Military Infectious Diseases Research Program
2. Combat Casualty Care Research Program
3. Military Operational Medicine Research Program
4. Clinical and Rehabilitative Medicine Research Program
5. Medical Biological Defense Research Program
6. Medical Chemical Defense Research Program
7. Medical Simulation and Information Sciences Research Program
8. Radiation Health Effects Research Program
9. Special Investment Areas/Innovation Funding
Office of Strategic Initiatives (OSI): Case School of Medicine's OSI can work with you to make sure that you meet the current goals and objectives of the USAMRMC that is paramount for your success. OSI can assist you in preparing a competitive proposal and can help guide your efforts from the first draft of the pre-proposal to submission of the full application.
Timeline: Invitation to submit a Full proposal will be given within 90 days of submission of the pre-proposal. An additional 90 days is provided to the applicant to complete the full application. Allow for at least 6 months between submission of the whitepaper to submission of the full application.
Contact us: If you are planning on submitting a pre-proposal, have questions, or would like more information - contact OSI Project Manager Irene Shaland - email@example.com - 216.368.4970
The Ohio Clinical Trial Collaborative (OCTC)
The Ohio Clinical Trial Collaborative OCTC is developing partnerships with the drug industry to include Biotech and Pharmaceutical industries to perform clinical drug trials phase I-4. The OCTC is a network of Ohio based hospitals led by working groups in areas such as neuro oncology, pediatrics, infectious disease, and neuroscience. The OCTC was launched at the BIO2014 which was attended by 15,000 biotech and pharmaceutical executives in San Diego resulting in numerous leads for potential drug trials.
The OCTC has plans to attend additional biotech and pharmaceuticals shows. The OCTC is looking for additional working groups interested in developing a sell sheet that can then be searched on the World Wide Web and will begin sales and marketing activities to identify opportunities with industry. If there are companies that individuals would like OCTC to target, the group welcomes that feedback.
Review the OCTC working website at: http://ohioclintrials.org.
Contact Joe Peter at 216-702-5314 for more information.
If you have news or information that you wish to have included in this
update, please send it via e-mail to Tracy Wilson-Holden at
firstname.lastname@example.org no later than
5 pm on the Monday of the week that the update is to be distributed. If you
know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe
to Case Research News, email your request to Tora Williams at
Please note: At the time of this transmission, all links functioned.
However, Case Research News cannot guarantee that the information will not move or be